Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 25,412 | 15,347 | 7,275 | 6,398 | 7,674 |
| Cost of Goods | 11,486 | 8,364 | 3,514 | 2,773 | 4,764 |
| Gross Profit | 13,926 | 6,983 | 3,761 | 3,625 | 2,910 |
| Operating Expenses | 32,449 | 36,890 | 27,801 | 26,061 | 20,168 |
| Operating Income | -18,037 | -29,543 | -23,526 | -21,663 | -16,494 |
| Interest Expense | 2,876 | 2,031 | 2,790 | 2,261 | 898 |
| Other Income | 1,735 | 1,928 | 970 | 371 | 370 |
| Pre-tax Income | -19,178 | -29,646 | -25,346 | -23,553 | -17,022 |
| Income Tax | -50 | -147 | 105 | N/A | N/A |
| Net Income Continuous | -19,128 | -29,499 | -25,451 | -23,553 | -17,022 |
| Net Income | $-19,128 | $-29,499 | $-25,451 | $-23,553 | $-16,385 |
| EPS Basic Total Ops | -11.02 | -17.85 | -9.21 | -2.53 | -1.82 |
| EPS Basic Continuous Ops | -11.02 | -17.85 | -9.20 | -2.53 | -1.89 |
| EPS Diluted Total Ops | -11.02 | -17.85 | -9.21 | -2.53 | -1.82 |
| EPS Diluted Continuous Ops | -11.02 | -17.85 | -9.20 | -2.53 | -1.89 |
| EBITDA(a) | $-16,097 | $-27,576 | $-21,388 | $-20,204 | $-15,176 |